Amplicon sp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2014-03-14
Share capital
20,000.00 PLN
Activity description

Amplicon is a biotechnology company that specializes in developing diagnostic tests based on real-time PCR technology, utilizing data from DNA sequences. They provide precise and reliable diagnostic tests for infectious and genetic diseases in both humans and animals, and they also design, optimize, and validate molecular diagnostic assays. Additionally, they conduct a range of highly specialized molecular research studies.

Registered address
ul. Klecińska 125, 54-413 Wrocław, Poland
Opening hours
Mon–Fri, 8:00–15:00
Email
Phone
Electronic delivery address
AE:PL-17762-91725-JSDFD-17

Financials

Revenue history (in k)

Financial insight

  • The statement flags a going concern risk. Podczas Walnego Zgromadzenia Wspólników z dnia 28 maja 2025 r. Wspólnicy podjęli uchwałę, według której Spółka ulegnie likwidacji pomiędzy 1 września 2026r. a 31 grudnia 2026 r.

Filing timeliness

Financial statements were filed on time, on average 36 days early.

  • 202512/07/2026
  • 202405/06/2025
  • 202317/06/2024
  • 202205/07/2023
  • 202121/06/2022
  • 202029/06/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 84%
Sector · Manufacturing20,990 / 24,548
Top 86%
City · Wrocław9,897 / 13,650
Top 73%
Voivodeship · Dolnośląskie17,934 / 23,831
Top 75%
Country · Poland222,974 / 297,069
Top 75%

Results vs industry

Revenue
This companyUSD 48.33kMedianUSD 913.43kAverageUSD 25.82m
Net profit
This companyUSD -54.32kMedianUSD 14.22kAverageUSD 2.77m
Operating costs
This companyUSD 102.19kMedianUSD 846.99kAverageUSD 21.42m
Assets
This companyUSD 69.63kMedianUSD 897.46kAverageUSD 31.52m

Offer

  • PCR diagnostic kits
  • Pathogen diagnostic panels
  • DNA polymorphism analysis kits
  • Genetic diagnostics
  • Diagnostic kit design

Websites

  • amplicon.plAmplicon – technologie oparte na sekwencji DNA
    WordPress 7.1ElementorNginx

Public procurement

6 tenders recorded as contractor, with a total value of $72,894.

SubjectAmount
Diagnostic tests II
$968
Diagnostic tests III
$2,234
Diagnostic tests I
$10,663

Authorized Representatives

Janusz Krzysztof Piechota age 49 – President of the Management Board
Małgorzata Piskozub age 44 – Vice President of the Management Board

Manner of representation

In the case of a multi-member management board: the members of the management board act independently.

Ownership

OwnerSharesShare valueStake
10$2,701.2450%
10$2,701.2450%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2014-05-01.

  • mBank
    34 1140 2004 0000 3102 7510 2857

Debt

No entries in the National Debtors Register (KRZ).

Public aid

13 public aid cases recorded, with a total value of $92,844.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$122
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$296
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$243

European Funds

ProjectEU co-financing
Development and validation of a panel diagnostic test to assess the risk of developing dementia and implement a personalized pharmacological therapy method and an algorithm for interpreting results
$174.9K

Competitors

Name
Farmabol sp. z o.o.
Vitrotest Europe sp. z o.o.
Kosma Pharma Group sp. z o.o.
GMT Genomics S.A.
Replicon sp. z o.o.
Grupa Psychotronics sp. z o.o.
Biotransplant Research sp. z o.o.

Change history

DateEvent
2019-06-05PKD change
2019-03-22Address change
2014-03-14Entered in the register

FAQ

Last updated: 2026-10-07